DRIIVE (Data and Research on Interventions to Improve the Vehicular Environment)

NCT02381626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2021-10-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to look at air quality in cabs and see if the air quality inside taxi cabs is connected to increased risks for lung and heart health problems. Another purpose of the study is to see if putting an air filter inside the car may help improve the air quality and lower health risks.

This is important because air pollution can be harmful to health. Air pollution is made up of very tiny particles (things) floating in the air around us, called particulate matter. Particulate matter is made up of dust, smoke, dirt, and gas fumes and can get into our bodies as we breathe. It has been linked to risk for lung cancer and heart disease. It is important because taxi drivers spend many hours of their day inside their cars.

The investigators hope that this study will help them find out if using air filters inside cabs will help lower the levels of pollution in cabs and reduce its effects on the health of taxi drivers. They will use these results to educate the taxi driver community.

Conditions

  • Vehicular Environment

Interventions

DEVICE

HEPA air purifier

air purifiers to remove PM and volatile organic compounds will be placed in drivers cars

BEHAVIORAL

questionnaires

OTHER

Log-book

PM and biological measurements

OTHER

Urine sample

PAH (Polycyclic Aromatic Hydrocarbon) will be assessed via urine sample collection of Urinary 1 hydroxy pyrene and particulate matter collected via Polyurethane Foam Filter (PUF) sampler

Sponsors & Collaborators

  • New York University

    collaborator OTHER
  • New York State Department of Health

    collaborator OTHER_GOV
  • The City College of New York

    collaborator OTHER
  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • Jennifer Leng, MD, MPH · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2020-10-18
Completion
2020-10-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02381626 on ClinicalTrials.gov